Shenzhen Maternity & Child Healthcare Hospital
10
3
3
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
10%
1 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
A Study of the Intervention of Time-restricted Eating in High-risk Populations of GDM
Role: collaborator
A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01)
Role: collaborator
Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women With Placenta Previa
Role: collaborator
Predictive Value of Maternal Blood Protein Signatures in Preterm Birth
Role: collaborator
Maternal Serum Markers Predicting Preeclampsia At Early Gestations
Role: collaborator
First Live Birth Rate With eSET After Preimplantation Methylome Screening (PIMS) Versus Conventional In-vitro Fertilization
Role: collaborator
Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU
Role: lead
The Feasibility of an Online Intergenerational Co-parenting Program
Role: collaborator
Correlation Between Premature Rupture of Membranes and Early-onset Neonatal Infections
Role: collaborator
Early Usage of Bakri Ballon in Managing Postpartum Hemorrhage
Role: collaborator
All 10 trials loaded